Accordingly, butyrate, as an inhibitor of histone deacetylation, inhibits the growth of liver cancer cells via down-regulation of cdc2 and cyclin E and cyclin B1 in oral cancer cells [28,29]. The gene discussed is CCNB1; the disease is liver cancer.